Glucose-galactose malabsorption

Jump to: navigation, search


Glucose-galactose malabsorption
ICD-10 E74.3
ICD-9 271.3
OMIM 182380
DiseasesDB 29845

WikiDoc Resources for Glucose-galactose malabsorption

Articles

Most recent articles on Glucose-galactose malabsorption

Most cited articles on Glucose-galactose malabsorption

Review articles on Glucose-galactose malabsorption

Articles on Glucose-galactose malabsorption in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Glucose-galactose malabsorption

Images of Glucose-galactose malabsorption

Photos of Glucose-galactose malabsorption

Podcasts & MP3s on Glucose-galactose malabsorption

Videos on Glucose-galactose malabsorption

Evidence Based Medicine

Cochrane Collaboration on Glucose-galactose malabsorption

Bandolier on Glucose-galactose malabsorption

TRIP on Glucose-galactose malabsorption

Clinical Trials

Ongoing Trials on Glucose-galactose malabsorption at Clinical Trials.gov

Trial results on Glucose-galactose malabsorption

Clinical Trials on Glucose-galactose malabsorption at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Glucose-galactose malabsorption

NICE Guidance on Glucose-galactose malabsorption

NHS PRODIGY Guidance

FDA on Glucose-galactose malabsorption

CDC on Glucose-galactose malabsorption

Books

Books on Glucose-galactose malabsorption

News

Glucose-galactose malabsorption in the news

Be alerted to news on Glucose-galactose malabsorption

News trends on Glucose-galactose malabsorption

Commentary

Blogs on Glucose-galactose malabsorption

Definitions

Definitions of Glucose-galactose malabsorption

Patient Resources / Community

Patient resources on Glucose-galactose malabsorption

Discussion groups on Glucose-galactose malabsorption

Patient Handouts on Glucose-galactose malabsorption

Directions to Hospitals Treating Glucose-galactose malabsorption

Risk calculators and risk factors for Glucose-galactose malabsorption

Healthcare Provider Resources

Symptoms of Glucose-galactose malabsorption

Causes & Risk Factors for Glucose-galactose malabsorption

Diagnostic studies for Glucose-galactose malabsorption

Treatment of Glucose-galactose malabsorption

Continuing Medical Education (CME)

CME Programs on Glucose-galactose malabsorption

International

Glucose-galactose malabsorption en Espanol

Glucose-galactose malabsorption en Francais

Business

Glucose-galactose malabsorption in the Marketplace

Patents on Glucose-galactose malabsorption

Experimental / Informatics

List of terms related to Glucose-galactose malabsorption

Overview

Glucose-galactose malabsorption is a condition in which the cells lining the intestine cannot take in the sugars glucose and galactose, which prevents proper digestion of these molecules and larger molecules made from them.

Glucose and galactose are called simple sugars, or monosaccharides. Sucrose and lactose are called disaccharides because they are made from two simple sugars, and are broken down into these simple sugars during digestion. Sucrose is broken down into glucose and another simple sugar called fructose, and lactose is broken down into glucose and galactose. As a result, lactose, sucrose and other compounds made from carbohydrates cannot be digested by individuals with glucose-galactose malabsorption.

Glucose-galactose malabsorption generally becomes apparent in the first few weeks of a baby's life. Affected infants experience severe diarrhea resulting in life-threatening dehydration, increased acidity of the blood and tissues (acidosis), and weight loss when fed breast milk or regular infant formulas. However, they are able to digest fructose-based formulas that do not contain glucose or galactose. Some affected children are better able to tolerate glucose and galactose as they get older.

Small amounts of glucose in the urine (mild glucosuria) may occur intermittently in this disorder. Affected individuals may also develop kidney stones or more widespread deposits of calcium within the kidneys.

Glucose-galactose malabsorption is a rare disorder; only a few hundred cases have been identified worldwide. However, as many as 10 percent of the population may have a somewhat reduced capacity for glucose absorption without associated health problems. This condition may be a milder variation of glucose-galactose malabsorption. What genes are related to glucose-galactose malabsorption?

The SLC5A1 gene provides instructions for producing a sodium/glucose cotransporter protein called SGLT1. This protein is found mainly in the intestinal tract and, to a lesser extent, in the kidneys, where it is involved in transporting glucose and the structurally similar galactose across cell membranes. The sodium/glucose cotransporter protein is important in the functioning of intestinal epithelial cells, which are cells that line the walls of the intestine. These cells have fingerlike projections called microvilli that absorb nutrients from food as it passes through the intestine. Based on their appearance, groups of these microvilli are known collectively as the brush border. The sodium/glucose cotransporter protein is involved in the process of using energy to move glucose and galactose across the brush border membrane for absorption, a mechanism called active transport. Sodium and water are transported across the brush border along with the sugars in this process.

Mutations that prevent the sodium/glucose cotransporter protein from performing this function result in a buildup of glucose and galactose in the intestinal tract. This failure of active transport prevents the glucose and galactose from being absorbed and providing nourishment to the body. In addition, the water that normally would have been transported across the brush border with the sugar instead remains in the intestinal tract to be expelled with the stool, resulting in dehydration of the body's tissues and severe diarrhea.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive disorder each carry one copy of the altered gene but do not show signs and symptoms of the disorder. In some cases, individuals with one altered gene have reduced levels of glucose absorption capacity as measured in laboratory tests, but this has not generally been shown to have significant health effects.

See also

Reference



Linked-in.jpg